Financial Performance - Uni-President China (00220.HK) reported a net profit of RMB 1.2867 billion for the first half of 2025, an increase of 33.2% year-on-year [1] - The company's revenue for the first half of 2025 reached RMB 17.0866 billion, up 10.6% compared to the same period last year [1] - The gross profit margin improved to 34.3%, a rise of 0.5 percentage points from the previous year [1] Business Segments - The food segment generated revenue of RMB 5.3822 billion, an increase of 8.8% year-on-year, accounting for 31.5% of total revenue [1] - The beverage segment reported revenue of RMB 10.7881 billion, up 7.6% year-on-year, making up 63.1% of total revenue [1] - The overall gross profit increased from RMB 5.228 billion to RMB 5.8648 billion, a rise of 12.2% [1] Operational Insights - The increase in gross profit margin was attributed to sales growth leading to enhanced production capacity and a decline in some raw material prices [1]

Core Viewpoint - The company, Zhizi City Technology (9911.HK), anticipates significant growth in revenue and profit for the first half of 2025, driven by the dual development of its social and innovative businesses, as well as the impact of acquiring non-controlling interests in NBT Social Networking Inc. by the end of 2024 [1] Financial Performance - Total revenue for the six months ending June 30 is expected to be approximately RMB 3.135 to 3.215 billion, representing a year-on-year increase of about 38% to 41.5% [1] - Net profit attributable to shareholders is projected to be around RMB 470 to 510 million, reflecting a year-on-year growth of 108.9% to 126.7% [1] - Adjusted EBITDA is estimated to be between RMB 630 to 670 million, indicating a year-on-year increase of approximately 40.6% to 49.6% [1] Growth Drivers - The profit increase is attributed to the company's utilization of AI technology to drive steady growth in diverse social products [1] - The completion of the acquisition of NBT Social Networking Inc. in December 2024 has contributed to the financial performance being fully attributable to the company's equity shareholders [1]

Performance Highlights - BeiGene (06160.HK) reported a revenue of 17.518 billion yuan for the first half of the year, a year-on-year increase of 46%; product revenue was 17.36 billion yuan, up 45.8%; net profit was 450 million yuan, turning from loss to profit [2] - Uni-President China (00220.HK) achieved approximately 17.087 billion yuan in revenue for the first half, a year-on-year increase of 10.6%; net profit was about 1.287 billion yuan, up 33.2% [2] - Zhiyu City Technology (09911.HK) announced a positive profit forecast, expecting mid-term revenue of approximately 3.135 to 3.215 billion yuan, a year-on-year increase of about 38.0% to 41.5%; net profit is expected to be around 470 to 510 million yuan, a year-on-year growth of approximately 108.9% to 126.7% [2] Earnings Forecasts - New World Development Company (00086.HK) expects mid-term net profit to increase to no less than 800 million HKD year-on-year [3] - Weizhi Jinkou (02003.HK) anticipates mid-term net profit exceeding 200 million HKD, a significant increase year-on-year [3] - Wing Chan Industrial (01596.HK) forecasts mid-term net profit of approximately 48.7 million HKD, turning from loss to profit [3] - Huaxian Optoelectronics (00334.HK) expects mid-term net profit to exceed 48.8 million HKD, a year-on-year increase of over 600% [3] - Maifushi (02556.HK) predicts mid-term net profit of approximately 31.8 to 41 million HKD, turning from loss to profit [4] - Xinwei Medical-B (06609.HK) expects mid-term net profit to exceed 40 million HKD, turning from loss to profit [5] - China Nuclear Technology (00611.HK) anticipates mid-term net profit growth of over 15% [6] Earnings Warnings - Hongxing Printing Group (00450.HK) expects mid-term net loss of approximately 49 million HKD, a significant increase year-on-year [7] - Zhongyu Land (01224.HK) forecasts mid-term net loss of approximately 40 million HKD, turning from profit to loss [7] - Beihai Group (00701.HK) anticipates mid-term net loss of 36 to 40 million HKD [8] Real Estate Sales Data - China Overseas Development (00688.HK) reported cumulative contract property sales of approximately 132 billion yuan for the first seven months, a year-on-year decrease of 18.3% [9] - Yuexiu Property (00123.HK) achieved cumulative contract sales of approximately 67.506 billion yuan for the first seven months, a year-on-year increase of about 11.7% [9] - Poly Property Group (00119.HK) reported contract sales of approximately 29.5 billion yuan for the first seven months, a year-on-year decrease of 13.49% [10] - China Overseas Hongyang Group (00081.HK) reported cumulative contract sales of 18.649 billion yuan for the first seven months, a year-on-year decrease of 12.2% [10] - Jindi Commercial Real Estate (00535.HK) reported cumulative contract sales of approximately 6.98 billion yuan for the first seven months, a year-on-year decrease of 37.37% [10] - Agile Group (03383.HK) reported pre-sale amount of approximately 5.69 billion yuan for the first seven months [11] - Hongyang Real Estate (01996.HK) reported cumulative contract sales of 3.208 billion yuan for the first seven months, a year-on-year decrease of 41.6% [12] - Zhengrong Real Estate (06158.HK) reported cumulative contract sales of approximately 2.701 billion yuan for the first seven months, a year-on-year decrease of 30.6% [12] - Jingrui Holdings (01862.HK) reported cumulative contract sales of approximately 571 million yuan for the first seven months, a year-on-year decrease of 52.54% [13] Company News - CITIC Securities (06030.HK) reported that its subsidiary, Huaxia Fund, achieved revenue of 4.258 billion yuan and net profit of 1.123 billion yuan in the first half, with assets under management totaling 285.1237 billion yuan [14] - Xinyi International (00732.HK) reported a cumulative operating revenue of approximately 9.566 billion HKD for the first seven months, a year-on-year decrease of about 5.3% [15] - Heng Rui Pharmaceutical (01276.HK) received orphan drug designation from the US FDA for its injection of Rikan Trastuzumab combined with Adebali for gastric cancer or gastroesophageal junction adenocarcinoma indications [15] - Fuhong Hanlin (02696.HK) completed the first patient dosing in a Phase II clinical study of HLX79 injection combined with Hanlikang® for active renal glomerulonephritis in China [15] - China Biopharmaceutical (01177.HK) announced that its self-developed TQ05105 (JAK/ROCK inhibitor) has been included in the breakthrough therapy designation program for the treatment of chronic graft-versus-host disease [15] Buyback Activities - HSBC Holdings (00005.HK) repurchased approximately 1.65 billion HKD worth of about 1.714 million shares at a price of 95.8 to 96.75 HKD [16] - Hang Seng Bank (00011.HK) spent approximately 22.6347 million HKD to repurchase 200,000 shares at a price of 112.8 to 113.6 HKD [17] - Yum China (09987.HK) repurchased approximately 6.264 million HKD worth of 16,800 shares at a price of 369.8 to 376 HKD [17]

Core Viewpoint - The company, Zhizi City Technology (9911.HK), anticipates significant growth in revenue and profit for the first half of 2025, driven by the dual development of its social and innovative businesses, as well as the acquisition of non-controlling interests in NBT Social Networking Inc. completed at the end of 2024 [1] Financial Performance - Total revenue for the six months ending June 30 is expected to be approximately RMB 3.135 to 3.215 billion, representing a year-on-year increase of about 38% to 41.5% [1] - Net profit attributable to shareholders is projected to be around RMB 470 to 510 million, reflecting a year-on-year growth of 108.9% to 126.7% [1] - Adjusted EBITDA is estimated to be between RMB 630 to 670 million, indicating a year-on-year increase of approximately 40.6% to 49.6% [1] Growth Drivers - The profit increase is attributed to the company's utilization of AI technology to drive steady growth in diverse social products [1] - The financial performance of NBT Social Networking Inc. is fully attributed to the company's equity shareholders following the acquisition completed in December 2024 [1]

(ii)截至2025年6月30日止半年度公司的拥有人应占利润约为人民币4.70亿元至人民币5.10亿元，较2024 年同期增长约108.9%至126.7%。公司拥有人应占利润的有关预期增长主要归因于集团借助AI技术推动 多样化社交产品持续稳步增长，以及公司于2024年12月完成对NBT Social Networking Inc.(NBT Social Networking)非控股权益的收购，NBT Social Networking的财务业绩全数归属于公司的权益股东;及 (iii)截至2025年6月30日止半年度集团的经调整EBITDA约为人民币6.30亿元至人民币6.70亿元，较2024 年同期增长约40.6%至49.6%，有关预期增长主要归因于集团借助AI技术推动多样化社交产品持续稳步 增长。 赤子城科技(09911)发布公告，预期：(i)截至2025年6月30日止半年度集团的总收入约为人民币31.35亿元 至人民币32.15亿元，较2024年同期增长约38.0%至41.5%，有关预期增长主要归因于集团借助AI技术推 动多样化社交产品持续稳步增长; ...

格隆汇8月6日丨赤子城科技(09911.HK)公布盈利预告，截至2025年6月30日止半年度，预期集团的总收 入约为人民币31.35亿元至人民币32.15亿元，较2024年同期增长约38.0%至41.5%，有关预期增长主要归 因于集团借助AI技术推动多样化社交产品持续稳步增长。 截至2025年6月30日止半年度，预期公司的拥有人应占利润约为人民币4.70亿元至人民币5.10亿元，较 2024年同期增长约108.9%至126.7%。公司拥有人应占利润的有关预期增长主要归因于集团借助AI技术 推动多样化社交产品持续稳步增长，以及公司于2024年12月完成对NBT Social Networking非控股权益的 收购，NBT Social Networking的财务业绩全数归属于公司的权益股东。 截至2025年6月30日止半年度，集团的经调整EBITDA约为人民币6.30亿元至人民币6.70亿元，较2024年 同期增长约40.6%至49.6%，有关预期增长主要归因于集团借助AI技术推动多样化社交产品持续稳步增 长。 ...

NEWBORN TOWN INC. 赤子城科技有限公司 （於開曼群島註冊成立的有限公司） （股份代號：9911） 盈利預告 本公告由赤子城科技有限公司（「本公司」，連同其附屬公司統稱「本集團」）根據 《香港聯合交易所有限公司證券上市規則》（「《上市規則》」）第13.09(2)條及香港 法例第571章《證券及期貨條例》第XIVA部項下的內幕消息條文（定義見《上市規 則》）作出。 本公司董事（「董事」）會（「董事會」）謹此知會本公司股東及潛在投資者，根據對 本集團截至2025年6月30日止半年度的未經審核綜合管理賬目及現時可得資料之 初步審閱，預期： 1 (i) 截至2025年6月30日止半年度本集團的總收入約為人民幣3,135百萬元至人民 幣3,215百萬元，較2024年同期增長約38.0%至41.5%，有關預期增長主要歸 因於本集團借助AI技術推動多樣化社交產品持續穩步增長； (ii) 截至2025年6月30日止半年度本公司的擁有人應佔利潤約為人民幣470百萬元 至人民幣510百萬元，較2024年同期增長約108.9%至126.7%。本公司擁有人 應佔利潤的有關預期增長主要歸因於本集團借助AI技術推動多樣化社 ...

| 代码 | 名称 | 最新价 | 涨跌额 | 涨跌幅 | | --- | --- | --- | --- | --- | | 800000 | 恒生指数 | 24746.81 | +13.36 | 0.05% | | 800100 | 国企指数 | 8896.03 | +2.55 | 0.03% | | 800700 | 恒生科技指数 | 5489.47 | +8.22 | 0.15% | (责任编辑：宋政 HN002) 【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容 的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱： news_center@staff.hexun.com 格隆汇8月5日｜隔夜美股三大指数均涨超1.3%，热门科技股普涨，中概指数涨1.33%。昨日止跌反弹的 港股三大指数微幅高开，恒指涨0.05%，国指涨0.03%，恒生科技指数涨0.15%。盘面上，大型科技股多 数上涨，其中，快手涨2%，腾讯、网易、京东、小米均有涨幅，美团、百度、阿里巴巴飘绿；生物医 药股再度活跃，泰格医药(300347)涨 ...

Group 1 - The 22nd China International Digital Interactive Entertainment Expo attracted over 800 exhibitors and more than 410,000 attendees, generating approximately 661 million yuan in surrounding service consumption [1] - The "2025 China Game Industry Report" indicates that both domestic and overseas market revenues for the Chinese gaming industry saw year-on-year growth in the first half of the year, with new growth opportunities and commercialization directions emerging [1] - The global mobile and PC gaming market is expected to exceed $120 billion by 2028, with mobile game in-app purchase revenue projected to grow by 6% in 2025, reaching $85.4 billion [1] Group 2 - Analysts noted that the gaming industry is experiencing a robust recovery, with increased foot traffic and player enthusiasm at this year's expo compared to last year [2] - The domestic mobile game market size grew by 20% year-on-year from January to May, while the number of domestic game licenses increased by 21% in the first half of the year, reaching a new high for June [2] - Gaming platforms are expected to benefit from increased user activity and advertising revenue, alongside the launch of new games and the steady operation of established titles [2] Group 3 - The gaming sector includes companies listed in Hong Kong such as Tencent (00700), NetEase-S (09999), Bilibili-W (09626), and others [3]

Core Insights - The 22nd China International Digital Interactive Entertainment Expo concluded, attracting over 800 exhibitors and more than 410,000 attendees, generating approximately 661 million yuan in surrounding service consumption [1] - The "2025 China Game Industry Report" indicates that both domestic and overseas market revenues for the Chinese gaming industry saw year-on-year growth in the first half of the year, with the industry scale continuing to expand [1] - Industry experts express strong confidence in the gaming sector, suggesting it is entering its best era, with new growth opportunities and commercialization directions emerging [1] Industry Trends - The global mobile and PC gaming market is expected to regain growth momentum, with a combined market size projected to exceed $120 billion by 2028 [1] - Mobile game in-app purchase revenue is forecasted to grow by 4% in 2024 and by 6% in 2025, reaching $85.4 billion, with expectations of $106.5 billion by 2028 [1] - Analysts from Citigroup noted increased enthusiasm at the expo, indicating a continued recovery for the Chinese gaming industry [1][2] Market Dynamics - The gaming industry is experiencing robust supply and demand, with the domestic mobile game market growing by 20% year-on-year from January to May, and the number of domestic game licenses increasing by 21% in the first half of the year [2] - The gaming community platforms are expected to benefit from the industry's high prosperity, with increased user activity potentially boosting advertising revenue without increasing ad load [2] - The successful reception of new games like NetEase's "Forgotten Sea" and Tencent's "Valorant" at the expo suggests a promising release schedule for the second half of the year [2] Related Companies - Key companies in the gaming sector include Tencent (00700), NetEase-S (09999), Bilibili-W (09626), Xindong Company (02400), Qingci Games (06633), Zhongyou Games (00302), Zhongxu Future (09890), Zhi Zi Cheng Technology (09911), and Friendship Time (06820) [3]